Indies Pharma bets on US market incursion
Pharmaceutical distributor Indies Pharma Limited indicates
that it is setting up a new beachhead in the United States with the hope of a
significant impact on future revenue.
Management stated in its most recent financial report, “Indies
Pharma has successfully entered into an agreement with a distributor in the
United States for distribution of our USFDA approved product in the United
States.
“ Again, Indies Pharma Ja had taken a bold and aggressive
step and can boast as the first Caribbean company that will manufacture and
distributes pharmaceutical product in United States. The product is well on
track for commercial sales and distribution by or before the end of the last
quarter of the fiscal year 2025.”
Management added, “ This is a proud milestone.”
For Indies Pharma net profit decreased by 9 per cent (J$ 6.5
million) in the current 2nd Quarter Period, compared to the prior year. Earnings
per share recorded a decrease of 9 per cent in the current 2nd Quarter Period
$0.048 from $0.053 in comparison to the prior year.
Net Profit increased by 3.2 per cent% (J$ 4.26 million) for
the current six-months period, compared to the prior year. Earnings per share
recorded an increase of 3.2 per cent to $0.103 for the current six-month
period, an increase from $0.100 in comparison to the prior year.
Caribbean Money Daily
Comments
Post a Comment